Matching slides 110,355
Current window 60,001-60,030
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

60,001-60,030 of 110,355

filter-aware
30
Standard corporate 'at-a-glance' summary slide.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
31
The slide uses a grid of icons and metrics to present company fundamentals and market size.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a flow diagram to show how business lines were reallocated between two reporting periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a three-column layout to categorize updates by business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a grid-based timeline to map four distinct drug development programs against calendar years from 2019 to 2027.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks financial performance changes for specific product lines following patent expirations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
The table compares inventory levels across two years, highlighting the change in months on hand for each business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
The table highlights inventory levels for specific business units, showing an increase in months on hand across all units in the 2021 period compared to 2020.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The slide highlights a 6% organic revenue growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
Includes detailed footnotes regarding non-GAAP adjustments and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
The slide highlights a 7% decline in combined WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
57
The table tracks revenue in millions of dollars for 10 products across 5 quarters (3Q20 to 3Q21).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table tracks revenue in millions for 10 product lines across 5 quarters (3Q20 to 3Q21).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table lists 10 products with their respective quarterly revenues in millions of dollars.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
Data represents international sales only.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
61
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
62
The table lists products by rank and their respective quarterly revenues in millions of dollars.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
65
The slide provides supplemental financial metrics for Bausch + Lomb, likely for valuation or segment analysis purposes.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The slide contains two distinct tables: one for Revenue and one for EBITA (non-GAAP).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
68
Includes footnotes regarding non-GAAP adjustments and fiscal year reporting.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The table provides a detailed breakdown of financial metrics for the International Rx segment, including non-GAAP EBITA.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
70
The table breaks down revenue into Ortho Dermatologics and Global Solta components.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit